Disruption of Tumor Necrosis Factor Receptor Associated Factor 5 Exacerbates Pressure Overload Cardiac Hypertrophy and Fibrosis

IKKi Deficiency Promotes Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis

(2013) Jia Dai et al.   PLoS One

Disruption of mindin exacerbates cardiac hypertrophy and fibrosis

(2012) Zhou-Yan Bian et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Molecular mechanisms in evolutionary cardiology failure

(2010) Bernard Swynghedauw et al.   Annals of the New York Academy of Sciences

Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy

(2010) Izhak Kehat et al.   Annals of the New York Academy of Sciences

Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling

(2010) Di-Fei Shen et al.   BRITISH JOURNAL OF PHARMACOLOGY

TRAF5 Deficiency Accelerates Atherogenesis in Mice by Increasing Inflammatory Cell Recruitment and Foam Cell Formation

(2010) Anna Missiou et al.   CIRCULATION RESEARCH

Mitogen-Activated Protein Kinase Signaling in the Heart: Angels Versus Demons in a Heart-Breaking Tale

(2010) Beth A. Rose et al.   PHYSIOLOGICAL REVIEWS

TRAF5 Is a Downstream Target of MAVS in Antiviral Innate Immune Signaling

(2010) Eric D. Tang et al.   PLoS One

Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload

(2010) H. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

NF- B activation is required for adaptive cardiac hypertrophy

(2009) L. Zelarayan et al.   CARDIOVASCULAR RESEARCH

Tumor Suppressor Ras-Association Domain Family 1 Isoform A Is a Novel Regulator of Cardiac Hypertrophy

(2009) Delvac Oceandy et al.   CIRCULATION

LIM and Cysteine-Rich Domains 1 Regulates Cardiac Hypertrophy by Targeting Calcineurin/Nuclear Factor of Activated T Cells Signaling

(2009) Zhou-Yan Bian et al.   HYPERTENSION

Molecular targets and regulators of cardiac hypertrophy

(2009) Agrawal Rohini et al.   PHARMACOLOGICAL RESEARCH

TRAF5 is a critical mediator of in vitro signals and in vivo functions of LMP1, the viral oncogenic mimic of CD40

(2009) Z. J. Kraus et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

αB-Crystallin Suppresses Pressure Overload Cardiac Hypertrophy

(2008) Asangi R.K. Kumarapeli et al.   CIRCULATION RESEARCH

Cellular repressor of E1A-stimulated genes attenuates cardiac hypertrophy and fibrosis

(2008) Zhouyan Bian et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway

(2008) Jun Cai et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3β signaling

(2008) Qizhu Tang et al.   JOURNAL OF MOLECULAR MEDICINE-JMM